MLN-4760

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameMLN-4760
Drug Alias NameMLN-4760ORE-1001GL-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaIndia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOre Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A